samedan logo
 
 
spacer
home > white papers > Optimize your Biologicís Analytical Program for Greater Risk Reduction - Merck
WHITE PAPERS
logo_Merck.jpg

Merck

phone +33 (0)5 57 960 960
email IECustomerrelations@merckgroup.com
web http://www.merckmillipore.com/GB/en
email 1 rue Jacques Monod, Site Montesquieu, 33650 Martillac, France

Optimize your Biologicís Analytical Program for Greater Risk Reduction

Analytical methods are used throughout upstream and downstream processes to help ensure the desired molecule is being produced with the desired purity. In addition to having the right molecule, quality must be confirmed in terms of glycosylation, oxidation, aggregates, activity and concentration. The analytical package must also ensure that all impurities from the manufacturing process and environment are consistently removed.
Optimize your Biologicís Analytical Program for Greater Risk Reduction
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Nemera reinforces its value proposition with a refreshing visual identity

At Nemera, we have been successfully providing high quality drug delivery device solutions to our customers and patients for years. We design and manufacture devices with the ultimate goal to improve patient outcomes and experience.
More info >>


White Papers

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

PCI Pharma Services

The deadlines for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-prepared to meet the target. Here, we look to the experience of a company that is ahead of the curve for lessons on how to manage and ease the transition to serialisation.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement